Similarly, in order to mount effective anti-cancer responses, T cells need to overcome a strongly inhibitory tumor microenvironment, characterized by the presence of Tregs and high levels of inhibitory cytokines such as TGFβ. This evidence concerns the gene TGFB1 and neoplasm.